Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation
| Autor: | Edward L. Korn, Emanuela Taioli, O. Wolf Lindwasser, Anna K. Nowak, Fred R. Hirsch, Anne S. Tsao, Aaron S. Mansfield, Ravi Salgia, Suzanne E. Dahlberg, Harvey I. Pass, Bruce W. S. Robinson, Hedy L. Kindler, Shakun Malik, Marjorie G. Zauderer, Andreas Rimner, Valerie W. Rusch, Rajeshwari Sridhara, Ritu R. Gill, Matthew L. Beyers, Michele Carbone, Joseph S. Friedberg, Alex A. Adjei, Dean A. Fennell, Gideon M. Blumenthal, Boris Sepesi, Ming-Sound Tsao, Mary Hesdorffer, Kenneth E. Rosenzweig, Haining Yang, Raphael Bueno, Julija Hmeljak, Daniel R. Gomez, Marc de Perrot, Geoffrey Liu, Tobias Peikert, Charles B. Simone, David H. Harpole, Prasad S. Adusumilli, Bryan M. Burt, Peter W. Szlosarek, Raffit Hassan |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
Pulmonary and Respiratory Medicine Oncology Mesothelioma medicine.medical_specialty Consensus Lung Neoplasms medicine.medical_treatment Multimodality Therapy Malignancy Targeted therapy 03 medical and health sciences 0302 clinical medicine Internal medicine medicine Humans Applied research Lung cancer business.industry Mesothelioma Malignant Cancer respiratory system medicine.disease National Cancer Institute (U.S.) United States respiratory tract diseases Clinical trial 030104 developmental biology 030220 oncology & carcinogenesis business |
| Zdroj: | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 13(11) |
| ISSN: | 1556-1380 |
| Popis: | On March 28- 29, 2017, the National Cancer Institute (NCI) Thoracic Malignacy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation convened the NCI-International Association for the Study of Lung Cancer- Mesothelioma Applied Research Foundation Mesothelioma Clinical Trials Planning Meeting in Bethesda, Maryland. The goal of the meeting was to bring together lead academicians, clinicians, scientists, and the U.S. Food and Drug Administration to focus on the development of clinical trials for patients in whom malignant pleural mesothelioma has been diagnosed. In light of the discovery of new cancer targets affecting the clinical development of novel agents and immunotherapies in malignant mesothelioma, the objective of this meeting was to assemble a consensus on at least two or three practice-changing multimodality clinical trials to be conducted through NCI's National Clinical Trials Network. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|